Arcturus Therapeutics Holdin

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.03

-0.44 (-5.89%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 79%

Hold 4 21%

Sell 0 0%

Price Target

Analyst Price Target +275.7% upside

Low Target $16.23

Average Target $26.41

High Target $33.18

Current Price $7.03

Current
$7.03

Target
$26.41

$16.23 $26.41 avg $33.18

Scenario Analysis

Bear Case

$16.23

130.9%

Low target

Base Case

$26.41

+275.7%

Avg target

Bull Case

$33.18

+372.0%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$24.17

-70.9% from high

52-Week Low

$5.85

+20.2% from low

Target vs 52W High

$26.41

+9.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+20.5%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.2%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+178.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.1%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-88.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-23.9%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.0%